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South American camelids are susceptible to tuberculosis, caused mainly by
Mycobacterium bovis and M. microti. Despite the tuberculin skin test being the official
test for tuberculosis, it has a very low sensitivity in these species (14–20%). Serological
tests present the advantages of being rapid, easy to perform and facilitate analysis
of large numbers of samples in a short period of time. Novel antigen discovery and
evaluation would provide enhanced detection of specific antibodies against members
of M. tuberculosis complex. Here, we describe the development and evaluation of an
ELISA-type immunoassays to use in the diagnosis of tuberculosis in llamas and alpacas
based on P22, a multiprotein complex obtained by affinity chromatography from bovine
Purified Protein Derivative (bPPD), that showed high sensitivity and specificity in mice,
cattle and goats. This work was performed in two stages. First, a preliminary panel of
samples collected from tuberculosis-free (n = 396) andM. bovis-infected herds (n = 56)
was assayed, obtaining high specificity (100%) and sensitivity ranging from 63 to 96%.
Subsequently, the use of the serological assay was tested using samples from two herds
suffering from clinical M. bovis (n = 88) and M. microti (n = 25) infection to evaluate
the ability of the ELISA to detect infected animals. 11 out of 88 alpacas were positive
to the ELISA in a M. bovis outbreak and 7 out of 25 in a M. microti outbreak. The P22
ELISA potentially provides a sensitive and specific platform for improved tuberculosis
surveillance in camelids.
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INTRODUCTION
To date, tuberculosis (TB) is one of the most important diseases globally, both in animals and
humans (1, 2). Animal TB has a broad range of domestic and wild mammal species hosts, including
South American Camelids (SAC) that have become increasingly popular as production animals in
recent years. Although llamas and alpacas are gaining more importance in fiber production (3, 4),
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these animals also have companion animal value and may
have regular contact with humans and other susceptible animal
species. SACs are a potential source of different pathogens that
might be transmitted to humans and could pose a risk to human
health (5). Among these diseases, alpacas and llamas are very
susceptible to TB, caused by bacteria from the Mycobacterium
tuberculosis complex (MTC), mainly by M. bovis and M. microti
(6, 7).
The diagnosis of tuberculosis in SAC has beenmainly based on
the tuberculin skin test, both single and comparative intradermal
tuberculin test (SIT and SCIT, respectively), but these show
poor performance in general in these species (8–10) and low
sensitivity between 14 and 20%. A sensitivity of only 14% was
found in one llama herd outbreak for animals that presented
with visible lesions at post-mortem examination within 3 months
of the SCIT test (11). In another report, only one llama tested
positive out of five that were subsequently found to have visible
lesions from which M. bovis was cultured (12). The interferon
gamma (IFN-γ) test, based on the stimulation of blood cells with
Purified Protein Derivatives (PPDs) and subsequent detection of
the IFN-γ released, has been also developed for the diagnosis of
TB, but it has been difficult to standardize, is labor-intensive,
and in SAC yields a low sensitivity and specificity (63.6 and
89.1%, respectively) (13). In addition, in-house and commercial
serological assays for the detection of specific antibodies have
been previously investigated with a wide range of results (8, 11–
14), but have been tested in a low number of animals.
Serological tests have been able to detect infected animals
before the onset of clinical disease (8). In addition, the booster
effect on the antibody response caused after injection of
tuberculin has been reported as a strategic option to increase
the sensitivity of serological assays in some species (15, 16).
In general terms, the specificity of the serological assays are
moderate to high, ranged from 84.6 to 98%, depending on the
study and serological test employed (13, 17, 18). However, they
showed low to moderate sensitivity, ranging from 43 to 75%,
even using sera samples collected after intradermal PPD injection
(7, 13, 17, 18). More details of the serological test evaluated in
SAC are provided in Table 1. For these reasons, it is necessary
to develop and evaluate new assays in order to provide more
sensitive and specific options for the serological diagnosis of TB
in SACs.
The aim of the present study was to develop and evaluate a
novel ELISA type assay for the detection of specific antibodies of
MTC in alpacas and llamas based on P22 multiprotein complex
(20), which is affinity-purified from the PPD ofM. bovis, and has
been shown to provide greater sensitivity in other host species
(15, 16). The P22-based ELISA was tested in serum samples from
alpacas naturally infected with M. bovis and M. microti from
Spain and England and uninfected llamas and alpacas from Peru
and England.
MATERIALS AND METHODS
This work was performed in two stages: the first one included a
preliminary panel of samples collected in TB-free and naturally
M. bovis-infected herds to set the optimal cut-off point and
calculate specificity and sensitivity of the ELISA; in a second
stage, two farms suffering from clinical TB infection under
different epidemiological situations were used to validate the test.
Handling of the animals, testing and sampling were performed by
accredited veterinarians. These were residual samples collected
as part of routine surveillance or during breakdown sampling.
All samples used in this study were serum samples. The animals
used in this study were not experimental animals. All handling
and sampling procedures were performed by veterinarians in
accordance with the local legislation (Real Decreto 53/2013 in
Spain, Ley de Protección y Bienestar animal N◦ 30407 in Peru,
and the The Veterinary Surgeon Act 1966 in England).
Assessment of Specificity and Sensitivity
The specificity of the serological tests was evaluated in two
different TB-free herds of alpacas and llamas located in different
regions in Peru (19). The first alpaca herd was located at
4,000m of altitude in La Libertad (northwest) and the second
llama herd was located at approximately 4,200m of altitude in
Puno (southeast). 120 alpacas (104 male and 16 female) and
40 llamas (all female) were tested. Both herds were considered
TB-free (based on long history of TB-free infection, absence
of compatible lesions and epidemiological investigations). No
lesions consistent with TB were observed in any animal in the 5
years prior to the study during slaughterhouse surveillance and
no TB outbreak was reported on farms near the herds of the
study. In addition, one TB-free herd from southern England was
also included. 236 samples were available from adult alpacas at
this herd including 93 males and 143 females. The regulatory
program for TB surveillance in SAC in England can be found in
the Bovine TB Eradication Programme for England (http://apha.
defra.gov.uk).
The sensitivity was evaluated using serum samples from
animals (n = 56) from a herd located in central Spain where an
M. bovis outbreak was detected. The herd was a mix of alpacas of
Suri and Huacaya breed. No previous history of TBs was reported
before this outbreak. In December 2011, field veterinarians
detected clinical signs (anorexia, cachexia, respiratory distress)
and/or sudden deaths in three alpacas. Compatible TB-like
lesions were observed in the post-mortem examination of one of
these alpacas andM. bovis infection was subsequently confirmed
by bacterial culture (18). A total of 67 animals were slaughtered
and subjected to post-mortem examination within 4 weeks after
the ante-mortem tests. Animals with positive M. bovis cultures
and/or presence of visible TB-like lesions compatible with TB
(n = 56) were included in the study to assess sensitivity. Serum
samples for detection of specific antibodies were collected prior
to PPD inoculation and 15 days after.
Testing the ELISA Under Field Conditions
in Two TB Outbreaks
The analysis was carried out in two herds with natural M. bovis
or M. microti infection confirmed by the presence of lesions
compatible with TB and/or microbiological culture. Herd A
consisted of 88 animals of Huacaya breed in England. This farm
was selected due to a TB outbreak commencing in November
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TABLE 1 | Details of different serodiagnostic tests in llamas and alpacas.












Alpaca 65 MPB83 43.1 – (18)
Llama and alpaca 160 MPB83 – 96.3 (19)
Alpacas 52 + 306 MPB70 and MPB83 69.2 97.4 (13)
Alpacas 52 + 257 M. bovis antigensa 66.7 96.9 (13)
VetTB STAT-PAK Llama 14 MPB83, ESAT-6 and
CFP-10
64.3 – (11)
Llama and alpaca 8 + 79 MPB83, ESAT-6 and
CFP-10
62.5 89.9 (8)
Llama and alpaca 52 + 279 MPB83, ESAT-6 and
CFP-10
73.1 94.6 (17)





Llama and alpaca 52 + 279 MPB70 and MPB83 75 97.5 (17)





Llama 14 M. bovis antigensb 100 – (11)
Llama and alpaca 8 + 79 M. bovis antigensc 87.5 97.5 (8)
nSe, number of TB positive animals used for evaluation of Se; nSp, number of negative animals used for evaluation of Sp.
abPPD, ESAT6, CFP10, Rv3616c, MPB83, MPB70, and an MPB70 peptide.
bESAT-6, CFP-10, MPB64, MPB59, MPB70, MPB83, the 16-kDa protein, the 38-kDa protein, two fusion proteins comprising CFP10/ESAT-6 and the 16-kDa protein/MPB83, and two
native antigens, bPPD and M. bovis culture filtrate.
cPurified recombinant proteins (ESAT-6, CFP10, MPB70, MPB83, Mtb8, Mtb48, Acr1, and the 38 kDa protein), two native antigens, MPB83 protein and M. bovis culture filtrate (MBCF),
and four protein fusions (CFP10/ESAT-6, Acr1/MPB83, F10, and F6).
2016. Two initial clinical cases were disclosed at necropsy with
compatible TB lesions and M. bovis was isolated. Subsequently,
a whole herd SCIT was performed and one alpaca was culled
on the basis of a positive test. This alpaca was found to have
lesions at necropsy. Serological testing took place 14 days later
using Enferplex and cervid-DPP tests: two animals tested positive
on the Enferplex test, were culled but found to have no visible
lesions. All animals were skin-tested again 3 months later (using
bovine tuberculin only) and also bled for further serological
analysis (Enferplex only) 10 days following the skin test. Three
animals were found positive on serology and were culled. At
necropsy examination, two of these animals had no visible
lesions while the third alpaca was found to have atypical lesions,
comprising multiple small caseous lesions in a prescapular lymph
node.
The herd B outbreak of TB was detected a herd of
approximately 80 animals located in England in July 2017. The
owner had performed surveillance serological testing (Enferplex)
in May and identified a single animal that tested positive. At
a retest 1 month later, the animal remained positive and was
culled voluntarily on the basis of suspicion of disease. He was
found to have lesions in the liver as well as bronchial and
hepatic lymph nodes but no lesions in the lungs. At whole herd
skin testing (SCIT), three further animals were disclosed and
culled, although no visible lesions were found. At serological
testing performed after the skin test, six animals were identified
as positive on Enferplex and culled. Five of these animals had
atypical lesions identified at post-mortem examination while the
sixth had typical lesions in the lungs. A seventh alpaca was culled
as a dangerous contact and also displayed atypical lesions at
necropsy. 25 samples were available for analysis from 22 Suri
alpacas (3 males and 19 females), one Huacaya male alpaca and
two male llamas.Mmicroti was never successfully cultured from
these cases although PCR testing of lesion material was positive
forMmicroti.
Development of an Indirect and a
Competitive ELISA
An in-house indirect ELISA that detects antibodies against a
protein complex named P22, purified by affinity chromatography
from bovine PPD [CZ Veterinaria (Porriño, Spain)] was
developed. The indirect ELISA was performed as described
previously with minor modifications (15). Briefly, plates were
coated with P22 (10µg/ml) and then blocked with 5% skimmed
milk powder solution in phosphate buffered saline (PBS). After
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three washes with PBS plus 0.05%Tween 20 (PBST), sera were
added in duplicate at 1:100 dilutions in skimmed milk and
incubated for 60min at 37◦C. The optimal dilution of test serum
was determined before by evaluating the reactivity of serum
diluted from 1:10 to 1:640. 100 µl of detection antibody (Anti-
llama IgG-HRP conjugate at 1:4,000 were added and the plates
were incubated for 30min at room temperature (RT). As before,
the secondary antibody was titrated from 1:1,000 to 1:8,000 to
choose the optimal dilution. The reaction was developed by
adding 100 µl of o-phenylenediamine dihydrochloride substrate
(FAST OPD, Sigma–Aldrich, St Louise, USA) incubated for
15min in darkness and RT conditions. After that, the reaction
was stopped with 50µl of H2SO4 (3N). The optical density (OD)
was measured at 492 nm with an ELISA reader.
Negative control serum was obtained from TB-free llama
previously described as M. bovis culture negative from TB-free
areas and was included in every plate in quadruplicate. Positive
controls were obtained from llamas previously described as
M. bovis-infected confirmed by the presence of TB compatible
lesions andM. bovis positive culture.
In order to reduce the cross-reactivity with non-tuberculous
mycobacteria (NTM), a competitive ELISA was included. In
this case the serum samples were diluted in skimmed milk
supplemented with avian PPD [CZ Veterinaria (Porriño, Spain)]
at 150µg/ml. Only samples that yielded positive results to the
indirect ELISA were analyzed by the competitive ELISA.
Data Treatment
Sample results were expressed as an ELISA percentage (E%),
calculated by the following formula: [sample E%= (mean sample
OD/(2 × mean of negative control OD)) × 100]. Specificity was
calculated in the TB-free population using the formula [Sp= true
negatives/(true negatives + false positives) × 100]. Sensitivity
was calculated in the TB-infected population by the formula
[Se = true positives/(true positives + false negatives) × 100].
The cut-off value was calculated using a ROC analysis and was
defined as the value at which the highest sum of Se plus Sp was
obtained (21). Confidence intervals for Se and Sp were calculated
using the 95% Wilson’s confident interval (Epitools, Ausvet Pty
Ltd., Canberra, Australia).
RESULTS
The ROC analysis evidenced the diagnostic value the P22 ELISA
in SAC (Figure 1). The cut-off value was defined as the ratio
of the mean sample OD to the double of the mean OD of
the negative control. The P22 ELISA with a cut-off value set
at 100 E% showed the best balance between sensitivity and
specificity. Modifying the cut-off value (>100E%<) resulted
in either a decreased specificity or a constant sensitivity and
a cut-off value of 100 was, therefore, chosen for the P22
ELISA.
The data including sensitivity, specificity, positive
predictive value, negative predictive value and area under
the curve (AUC), using confidence intervals of 95% (95%
CI) for the ELISA with a chosen cut-off value of 100,
are summarized in Table 2. Once the optimal cut-off was
calculated, the specificity and sensitivity was studied in greater
depth.
Determination of Test Specificity
Specificity of the P22 ELISA in llama and alpaca herds is shown
in Table 3. The 396 animals from TB-free herds were negative to
the indirect ELISA. Thus, overall the specificity of P22 indirect
FIGURE 1 | Diagnostic value graphics for the tuberculosis indirect ELISA in SACs when using the P22 as an antigen. Sensitivity (Se), specificity (Sp) and their
semi-sum are the percentages on the Y-axis and the cut-off value on the X-axis.
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TABLE 2 | Sensitivity (Se), specificity (Sp), positive predictive value (PPV), negative
predictive value (NPV) and area under the curve (AUC) with 95% confidence
intervals (CI95) in the chosen cut-off value of 100 for P22 indirect ELISA in llamas
and alpacas.
Se Sp PPV NPV AUC
% CI95 % CI95 % CI95 % CI95
62.5 49.4–74 100 99–100 100 90.1–100 95 92.4–96.7 0.91
TABLE 3 | Specificity and 95% Wilson’s confident interval of the ELISA using
serum samples from llama and alpacas taken before and 5 days after the SCIT
test.
Pre-SCIT Post-SCIT
Country Specie Total Na Spb Na Spb
Peru Alpaca 120 0 100 (96.9–100) 0 100 (96.9–100)
Peru Llama 40 0 100 (91.2–100) 0 100 (91.2–100)
UK Alpaca 236 0 100 (98.4–100) – –
Total 396 0 100 (99–100) 0 100 (97.7–100)
a Number of positive animals.
b 95% Confidence interval for specificity.
ELISA was 100% (95% CI 99–100) in llamas and alpacas. In the
absence of any positive animal, the competitive ELISA was not
carried out.
Determination of Test Sensitivity
The sensitivity achieved with P22 indirect ELISA in the samples
from Spain was 62.5% (35/56) (95% CI 49.4–74) before PPD
inoculation, and 96.4% (54/56) (95% CI 87.9–99) 15 days after
PPD inoculation (Table 4). The competitive ELISA showed
similar sensitivity.
Study of Two TB Outbreaks in England
M. bovis Outbreak
In herd A, of the 88 animal analyzed, 11 were positive to indirect
ELISA (Figure 2). However, three animals had E% over 150 and
the remaining eight animals had values between 100 and 150%.
The competitive ELISA showed similar results. The same three
animals had over E% 150 again and only seven were between 100
and 150%, one less than using the indirect ELISA. This animal
was negative in competitive ELISA and positive in indirect ELISA
maybe due to cross reaction by NTM. Considering that four
animals had visible lesions at necropsy, three were positive to
both the indirect and competitive ELISA.
M. microti Outbreak
In herd B, 25 serum samples were analyzed. Seven animals were
positive in both indirect and competitive ELISA. Only one animal
showed an E% value close to the cut-off point. The other six
animals that had an E% over 300 (Figure 2), had visible lesions
at post-mortem examination. Two animals with visible lesions at
necropsy were negative to the ELISAs.
TABLE 4 | Sensitivity and 95% Wilson’s confident interval of indirect (Ei) and
competitive ELISA (Ec) in TB-infected animals based on post-mortem examination
(culture positive and/or presence of visible TB lesions).
N of animals Pre-SCIT 15 days after SCIT









FIGURE 2 | Histogram of the ELISA E% value of individual llama or alpaca
tested by indirect ELISA using P22 as antigen in M. bovis and M. microti
outbreaks. The horizontal line represents the chosen cut-off value.
DISCUSSION
Since alpacas became an important animal in Europe and more
tools for the diagnosis of TB in alpacas are needed, our results
suggest that the indirect P22 ELISAs described here can provide
better sensitivity and specificity than other TB antibody detection
tests currently used in alpacas and could be used to detect both
M. bovis and M. microti infection in SAC. As the indirect ELISA
showed a specificity of 100%, and the purpose for the competitive
ELISA was to remove antibodies against proteins shared between
M. tuberculosis complex and non-tuberculous mycobacteria, the
competitive ELISA is not useful in this case to improve the
specificity of the diagnosis. Therefore, we focused on the indirect
ELISA and propose this ELISA as a new tool for the diagnosis of
TB in SACs.
Several serological tests for detection of antibodies against TB
described previously showed specificity range from 84 to 98%
(13, 17, 19). The P22 ELISA achieved an excellent specificity
of 100%, higher than all serological test described up to date
for diagnosis of TB in camelids. In addition, no effect of the
injection of PPD was observed. The number of animal included
in this study was large enough to have a reliable specificity data,
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including with samples 5 days after PPD injection. However,
further studies with samples taken 15 days after the skin test are
necessary to confirm this finding because 5 days post-PPD may
be insufficient to observe optimal antibody boost.
Regarding sensitivity, our ELISA yielded a moderate average
sensitivity of 62.5%, similar to those reported by other serological
assays in SACs, which are between 43 and 74% (13, 17, 18).
These results are similar to those obtained for TB in bovine using
a P22-based ELISA test (15). Using samples obtained 15 days
after skin test, the sensitivity of P22 ELISA increased to 96%.
This result was higher than reported by all previous serological
assays using samples 15 days post-skin test, which sensitivity
was between 77 and 89% (18). This boosting effect has been
reported in TB in goats, bovines and alpacas (16, 18, 22). Casal
et al. (22) demonstrated that sensitivity was significantly higher
in cattle using samples collected 15 days post-skin test (ranging
from 66.7 to 85.2%). Our results obtained using samples 15 days
after injection of PPD were promising and suggested that the
P22 ELISA could be a useful TB diagnostic tool in SACs. Taking
a blood sample at 15 days post-PPD injection would require
an additional veterinary visit, with an associate cost. For this
reason, it may not be suitable as a routine method. Despite the
costly strategy, the increase of the sensitivity to almost 100%
could justify its use in certain situations. The booster effect,
including the P22 ELISA, has also been described as a useful
approach in cases of explosive TB outbreaks in other species as
goats (16).
Humoral response occurs primarily in advances stage of
infection and its detection has been considered less effective in
early stages of TB infection (23, 24). However, although the
skin test is the official diagnostic test for TB in alpacas, SIT
test showed poor performances in terms of sensitivity and our
results showed a higher sensitivity than SIT. Similar results were
obtained previously (11, 13, 18). The combination of the skin
test and a serological assay could be an approach to maximize
the detection of infected animal instead of IFN-γ because
of low sensitivity and difficulties to perform (18). Therefore,
implementation of serology in parallel with the skin test could
reach sensitivity of 100% (18). Since serology represents a rapid
and inexpensive assay, a previous study recommended testing
the same samples using several serological assays for a better
diagnosis of infected animals (13). In this sense, our P22 ELISA
may serve as a preferred technique for the diagnosis of TB,
together with other serological assays or skin test. In addition,
previous published batches of P22 showed similar qualitative
and quantitative composition (20) and, consequently make P22 a
stable and reliable product.
TB in SACs is mainly caused by M. bovis and M. microti,
and has been reported in several European countries including
Spain, the Netherlands, Switzerland, Ireland and the UK (7,
9, 14, 25). The present study has demonstrated the potential
of the ELISA in serodiagnosis of TB due to M. bovis and
also M. microti. The high OD observed in six M. microti
and three M. bovis infected animals suggest a new promising
sensitive serological test. Moreover, out of four animals in M.
bovis outbreak and eight animals in M. microti outbreak with
visible lesions, three and six animals, respectively were positive
to the ELISA, showing a good ability to detect animals in
advance stages of diseases, which are considered to be the major
excretors of bacterias (26, 27). In addition, the low rates of
positive results found in the herd A also confirm the high
specificity of the assays. Eight and one animals in herds A and
B, respectively had an E% close to the cut-off. However, the
specificity of the ELISA was 100% and, for this reason, the cross-
reaction with other proteins in P22 shared with environmental
mycobacteria was discarded. The level of antibodies in these
animals was low and consequently the OD in the ELISA was also
low.
In conclusion, the new multiprotein complex named P22
could be an alternative antigen for the detection of specific M.
tuberculosis complex antibodies in SAC.Moreover, the P22-based
indirect ELISA can be used as a cost effective, rapid and reliable
tool for the large-scale screening and therefore, support the
detection and management of tuberculosis in llamas and alpacas.
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